PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
ACS Comb Sci. Author manuscript; available in PMC Feb 13, 2013.
Published in final edited form as:
PMCID: PMC3289975
NIHMSID: NIHMS350936
A Build/Couple/Pair Strategy for the Synthesis of Stereochemically Diverse Macrolactams via Head-to-Tail Cyclization
Mark E. Fitzgerald, Carol A. Mulrooney, Jeremy R. Duvall, Jingqiang Wei, Byung-Chul Suh, Lakshmi B. Akella, Anita Vrcic, and Lisa A. Marcaurelle*
Chemical Biology Platform, Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA
*To whom correspondence should be addressed. lisa_marcaurelle/at/h3biomedicine.com
Current address: H3 Biomedicine, 300 Technology Square, Cambridge, MA 02139
Abstract
A build/couple/pair (B/C/P) strategy was employed to generate a library of 7936 stereochemically diverse 12-membered macrolactams. All 8 stereoisomers of a common linear amine precursor were elaborated to form the corresponding 8 stereoisomers of two regioisomeric macrocyclic scaffolds via head-to-tail cyclization. Subsequently, these 16 scaffolds were further diversified via capping of two amine functionalities on SynPhase Lanterns. Reagents used for solid-phase diversification were selected using a sparse matrix design strategy with the aim of maximizing coverage of chemical space while adhering to a preset range of physiochemical properties.
We have a long-standing interest in the design and synthesis of small-molecule libraries that combine the structural complexity of natural products and the efficiency of high-throughput synthesis.1,2,3,4 Recent evidence has shown the importance of structural complexity as measured by sp3 content and the presence of stereocenters with the successful transition from discovery to the clinic.5 As such, macrocycles are an important class of organic molecules showing a variety of impressive biological activities.6,7 There are numerous macrocycles currently in development or approved by the FDA for clinical use, including natural products (1, Figure 1)8 and their derivatives (2),9 as well as some designed and synthesized de novo (3).10 The large occurrence of macrocycles in nature and their impressive biological activities may be derived from the fact that they often exhibit both pre-organization as well as flexibility, both of which can aid binding to biological targets.11,12 Based off of these observations, we have utilized macrocyclic compounds in the past as a source of diversity and structural complexity within our screening collection. In this work, we present a continuation of this effort to build a small-molecule library that contains macrocyclic compounds but occupies a distinct area of chemical space.810
Figure 1
Figure 1
Select bioactive macrocycles in development or approved for clinical use.
Utilizing a three phase build/couple/pair (B/C/P) synthetic strategy,13 we have previously reported a route to medium-sized rings and macrocycles (Figure 2) starting from 1,2-amino alcohol 4 and aldol-derived γ-amino acid 5.8,14 A key feature of the B/C/P strategy is the ability to generate the complete matrix of stereoisomers lending to the study of stereo/structure-activity relationships (SSAR) upon biological screening.8,15 Thus all eight stereoisomers of amine 6 were prepared and utilized in downstream pairing reactions including nucleophillic aromatic substitution (SNAr), Huisgen macrocyclization and ring-closing metathesis (RCM) to yield scaffolds 711. In the current study we have expanded this chemistry to include a pairing reaction which cyclizes the linear template from ‘head-to-tail’ (HtoT) leading to macrocycles 12 and 13. This pairing strategy increases the number of stereogenic centers contained within the ring as compared to the previously prepared scaffolds, as well as decreases the number of rotatable bonds present in the final compounds. As evident by a molecular shape-based diversity analysis derived from normalized principal moments of inertia (PMI) ratios1,16 macrolactams 12 and 13 occupy a distinct region of 3-dimensional space as compared to scaffolds 711 (Figure 3). Surprisingly, the HtoT scaffolds are much more rod-like than the RCM-derived macrolactams.
Figure 2
Figure 2
An aldol-based B/C/P strategy generating macrocycles and medium-sized rings via nucleophilic aromatic substitution (SNAr), ring-closing metathesis (RCM), Huisgen cycloaddition and head-to-tail (HtoT) cyclization.
Figure 3
Figure 3
(Principal moments of inertia (PMI) analysis of the HtoT macrolactam scaffolds as compared to previously prepared aldol-based scaffolds: RCM, Click (1,5 and 1,4) and SnAr (8 and 9).8 PMI ratios are plotted in the triangular scatter plot. Minimum energy (more ...)
At the onset of this project, we envisioned two potential pairing strategies to effect HtoT macrocyclization: (1) an intramolecular SNAr reaction or (2) macrolactamization (Figure 4). Due to the overall success of the intramolecular SNAr reaction for the formation of the medium sized rings 7 and 8 in our initial study,8 we first set our sights on the application of this method to access macrolactam 12. The synthesis of the SNAr substrate begins with allyl carbamate formation accomplished by treatment of amine 6 with allyl chloroformate under Schotten-Baumann conditions (Scheme 1). This was followed by TBS removal with TBAF and methylation of the resultant secondary alcohol with methyl iodide. This synthetic sequence led to orthogonally protected diamine 16 in 54–80% yield. The choice of DMF as a solvent and the use of excess MeI was imperative to prevent intramolecular carbamate formation. The terminal PMB and Boc protecting groups were removed simultaneously upon treatment with TFA in the presence of anisole as a cation scavenger. Amidation of the resulting crude amino alcohol was then accomplished resulting in SNAr substrate 14 in yields of 56–70% for the two steps.
Figure 4
Figure 4
Potential HtoT macrocyclization strategies
Scheme 1
Scheme 1
Synthesis of scaffold 12 via SNAr macrocyclization
The key SNAr macrocyclization was first attempted utilizing conditions developed in our previous studies.8,11 Treatment of 14 with NaH in THF at 0 °C led solely to the formation of oxazolidinone 18, which could not be avoided even with careful exclusion of water and the use of KH. Heating alcohol 14 in the presence of excess CsF was also attempted, which showed no consumption of starting material by LC/MS at room temperature but ultimately led to decomposition after extended heating (> 1 day). The use of DBU in DMF17 was also unsuccessful even after extended heating. Finally, desired product 12 could be obtained using TBAF in THF/DMF (in the prescence of 4 Å molecular sieves)18 however the yields were generally low (25–45%) and highly variable. In light of the problems encountered promoting this transformation we decided to shift our efforts to a macrolactamization approach via intermediate 15 (Figure 4).
The synthesis of 15 (Scheme 2) commenced with PMB deprotection of intermediate 6 via treatment with DDQ in buffered CH2Cl2. The primary alcohol was subsequently subjected to an intermolecular SNAr reaction with aryl fluoride 20, in the presence of TBAF and 4 Å molecular sieves in THF/DMF resulting in ether 21 in good yield (55–75%). Bis-deprotection of the Boc and t-butyl ester groups provided crude amino acid 15 which was gratifyingly converted to macrocyle 12 in good yield (83%) upon treatment with BOP-Cl in the presence of DIEA.
Scheme 2
Scheme 2
Synthesis of scaffold 12 via macrolactamization
In order to access the meta-alkoxynitro macrocycle (13), we next decided to investigate a modified synthetic route in which the intermolecular SNAr reaction was replaced with a Mitsunobu reaction19 to install the nitrobenzoic acid. As shown in Scheme 3, primary alcohol 19 was treated with phenol 22 in the presence of DIAD and PPh3 to give phenyl ether 23 in 75–85% yield. The Boc and t-butyl ester groups were removed with TFA and the resulting amino acid (24) cyclized in the presence of BOP-Cl to afford macrocycle 13 in 78% yield over two steps.
Scheme 3
Scheme 3
Synthesis of scaffold 13 via macrolactamization
With established routes to both the para- and meta-alkoxynitro scaffolds, all eight isomers of macrocycles 12 and 13 were synthesized in 5-g quantities in preparation for solid-phase library production. The key macrocyclization reaction proceeded in high yield for all eight isomers of the linear amine scaffold (Table 1). The stereochemistry of the precursors 12 and 13, along with the regiochemistry of the aryl nitro substitutent, did not appear to influence the cyclization efficiency with combined yields for the double deprotection and lactamization ranging from 75–88%.
Table 1
Table 1
Macrolactamization yields for all stereo- and regioisomers
In order to load the scaffolds onto solid-phase for library production, SynPhase Lanterns20 functionalized with a monomethoxy Backbone Amide Linker (BAL)21,22,23 were selected. Use of the BAL linker allows for loading via an amine (in this case an aniline) without sacrificing a diversity site. Immobilization would be achieved via reductive alkylation, while subsequent N-capping with sulfonyl chlorides, acid chlorides and isocyanates would afford the corresponding sulfonamides, amides and ureas upon cleavage with TFA. Thus, chemoselective reduction of the nitro functionality was achieved with SnCl2 to afford anilines 25 and 26 (Scheme 4) for loading onto solid-support. Of note, reduction of the meta-alkoxynitroaryl group proved more sluggish than the para regioisomer requiring heating at 60 °C for full conversion. Nitro reduction proceeded smoothly for all isomers in yields ranging from 80–89%.
Scheme 4
Scheme 4
Reduction of aryl nitro group (only one stereoisomer shown).
With ample quantities of all stereoisomers of anilines 25 and 26 in hand, a sparse matrix design strategy was implemented to select library members to be synthesized.24 A virtual library was constructed (for each scaffold) incorporating all possible building block combinations at R1 (aniline) and R2 (secondary amine) using a master list of reagents (R1 = sulfonyl chlorides, isocyanates and acid chlorides; R2 = sulfonyl chlorides, isocyanates, acids and aldehydes).25 This provided a virtual library of 7,845 compounds per scaffold. Physicochemical property filters were then applied to eliminate building block combinations that led to products with undesired physicochemical properties.26 The following property filters were applied to yield a total of 5363 compounds: MW ≤625, ALogP −1 to 5, H-bond acceptors and donors ≤10, rotatable bonds ≤10 and TPSA ≤140. In order to increase the percentage of ‘Lipinski compliant’ products, a ‘75/25’ rule was also implemented where 75% of all library members had MW <500. A total of 496 compounds per scaffold were selected from the remaining set using chemical similarity principles, maximizing diversity but retaining near neighbors for built-in SAR. The reagents selected for library production include 22 sulfonyl chlorides, 19 isocyanates and 26 acid chlorides for aniline capping (Chart 1) along with 2 sulfonyl chlorides, 3 isocyanates, 21 acids and 22 aldehydes for secondary amine capping (Chart 2). The same set of reagents was used for each stereo- and regioisomer, thereby maintaining the ability to generate SSAR for each building block combination. The property distribution for the selected products (7936 compounds total) is shown in Figure 5 and Table 2.
Chart 1
Chart 1
Building blocks for aniline capping (R1)
Chart 2
Chart 2
Building blocks for amine capping (R2)
Figure 5
Figure 5
Molecular weight and ALogP distribution for HtoT library members.
Table 2
Table 2
Property analysis for the HtoT library
As shown in Scheme 6 scaffolds 25a–h and 26a–h were loaded onto the BAL functionalized SynPhase L-series Lanterns via treatment with an excess of NaBH3CN in 2% AcOH/DMF at 40 °C for 3 days. (Lanterns were equipped with radio frequency transponders to enable tracking and sorting of library members.) Scaffolds 25 and 26 contain two handles for the introduction of appendage diversity: the immobilized aniline and a protected secondary amine, both suitable for reaction with various electrophiles. The first diversity site, the aniline, was reacted with a total of 68 building blocks including isocyanates, sulfonyl chlorides and acid chlorides.27,28 The second diversity site was then revealed via removal of the Alloc group upon treatment with Pd(PPh3)4 in the presence of excess 1,3–dimethyl barbituric acid. This secondary amine was capped with 49 building blocks including isocyanates, sulfonyl chlorides, acids and aldehydes. This was followed by cleavage from the Lantern, which was achieved by treatment with a 1:1 solution of TFA:1,2-dichloroethane, to afford a total of 7936 products with an average yield of 8.5 μmol/Lantern. On average, yields were slightly higher for the para-aniline derived compounds than the meta-aniline compounds (9.1 μmol vs 8.0 μmol).29
Scheme 6
Scheme 6
Solid-phase library synthesis on SynPhase monomethoxy BAL Lanterns
All library products were analyzed by ultra-performance liquid chromatography, and compound purity was assessed by UV detection at 210 nm. An overview of library purity with respect to building blocks and stereochemistry is provided in Figure 6. The average purity of the library was 86% with 84% of the library being >75% pure. In general all building blocks performed well during library production other than a few which are worth discussion. Reagents used for capping diversity site 1 which resulted in lower purities include ethyl sulfonyl chloride (R1 = 2) and cyclopentyl isocyanate (R1 = 25), both of which affected products predominantly for the meta- cores across most diversity site 2 building blocks. Isoxazole acid chloride (R1 = 63) led to low purity final compounds for most of the 16 cores and diversity site 2 building blocks. Overall, building blocks used to diversify the secondary amine faired better in terms of final product purity, with only one building block (oxazole-4-carbaldehyde - R2 = 47) showing reduced purities across R1 building blocks.
Figure 6
Figure 6
Purity analysis (UV 210 nm) for the HtoT Library. Library members are displayed as blocks of 16 isomers (8 stereoisomers X 2 regioisomers) (see legend) and reagents used for solid-phase diversification are shown on the x- and y-axes. See Charts 1 and (more ...)
A novel library of 7936 12-membered macrocycles was successfully prepared via a macrocyclization pairing reaction. 16 cores were synthesized from 8 isomers of linear amine scaffold 9 to establish “built-in” stereo-structure activity relationships (SSAR). Two regioisomers of aniline capping site were also included in our design to further increase skeletal diversity. This library was generated utilizing a traceless BAL linker to provide final compounds that contained less rotatable bonds and one less potential H-bond donor in an effort to provide more “drug like” compounds for our screening collection. A sparse matrix of building blocks was employed to further enhance the appendage diversity of our library, while including built-in structure activity relationships and honing in on a desirable range of physiochemical properties.
Supplementary Material
1_si_001
Acknowledgments
This work was funded in part by the NIGMS-sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD; P50 GM069721), as well as the NIH Genomics Based Drug Discovery U54 grants Discovery Pipeline RL1CA133834 (administratively linked to NIH grants RL1HG004671, RL1GM084437, and UL1DE019585).
1. Marcaurelle LA, Comer E, Dandapani S, Duvall JR, Gerard B, Kesavan S, Lee MD, Liu H, Lowe JT, Marie JC, Mulrooney CA, Pandya BA, Rowley A, Ryba TD, Suh BC, Wei J, Young DW, Akella LB, Ross NT, Zhang YL, Fass DM, Reis SA, Zhao WN, Haggarty SJ, Palmer M, Foley MA. An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. J Am Chem Soc. 2010;132:16962–16976. [PMC free article] [PubMed]
2. Comer E, Liu H, Joliton A, Claubat A, Johnson C, Akella LB, Marcaurelle LA. Fragment-based domain shuffling approach for the synthesis of pyran-based macrocycles. Proc Nat Acad Sci. 2011;108:6751–6756. [PubMed]
3. Kelly AR, Wei J, Kesavan S, Marie JC, Windmon N, Young DW, Marcaurelle LA. Accessing skeletal diversity using catalyst control: formation of n and n + 1 macrocyclic triazole rings. Org Lett. 2009;11:2257–2260. [PMC free article] [PubMed]
4. Gerard B, Duvall JR, Lowe JT, Murillo T, Wei J, Akella LB, Marcaurelle LA. Synthesis of a stereochemically diverse library of medium-sized lactams and sultams via SNAr cycloetherification. ACS Comb Sci. 2011;13:365–374. [PMC free article] [PubMed]
5. Lovering F, Bikker J, Humblet C. Escape from flatland: increasing saturation as an approach to improving clinical success. J Med Chem. 2009;52:6752–6756. [PubMed]
6. Driggers EM, Hale SP, Lee J, Terrett NK. The exploration of macrocycles for drug discovery: an underexploited structural class. Nat Rev Drug Discov. 2008;7:608–624. [PubMed]
7. Drahl C. Big hopes ride on big rings. Chem Eng News. 2009;87:54–57.
8. Pal S. A journey across the sequential development of macrolides and ketolides related to erythromycin. Tetrahedron. 2006;62:3171–3200.
9. Lee F, Borzilleri R, Fairchild C, Kamath A, Smykla R, Kramer R, Vite G. Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Cancer Chemother Pharmacol. 2008;63:157–166. [PubMed]
10. Marsault E, Peterson ML. Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery. J Med Chem. 2011;54:1961–2004. [PubMed]
11. Tyndall JDA, Fairlie DP. Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases. Curr Med Chem. 2001;8:893–907. [PubMed]
12. Wessjohann LA, Ruijter E, Garcia-Rivera D, Brandt W. What can a chemist learn from nature’s macrocycles?—a brief, conceptual view. Mol Divers. 2005;9:171–186. [PubMed]
13. (a) Nielsen TE, Schreiber SL. Towards the optimal screening collection: a synthesis strategy. Angew Chem Int Ed. 2008;47:48–56. [PMC free article] [PubMed](b) Schreiber SL. Organic chemistry: Molecular diversity by design. Nature. 2009;457:153–154. and references sited therein. [PubMed]
14. Pandya BA, Dandapani S, Duvall JR, Rowley A, Mulrooney CA, Ryba T, Dombrowski M, Harton M, Young DW, Marcaurelle LA. Practical asymmetric synthesis of β-hydroxy γ-amino acids via complimentary aldol reactions. Tetrahedron. 2011;67:6131–6137. [PMC free article] [PubMed]
15. (a) Zhang Q, Lu H, Richard C, Curran DP. Fluorous mixture synthesis of stereoisomer libraries: total syntheses of (+)-murisolin and fifteen diastereoisomers. J Am Chem Soc. 2004;126:36–37. [PubMed](b) Dandapani S, Jeske M, Curran D. Synthesis of all 16 stereoisomers of pinesaw fly sex pheromones--tools and tactics for solving problems in fluorous mixture synthesis. J Org Chem. 2005;70:9447, 9462. [PubMed]
16. Sauer WH, Schwarz MK. Molecular shape diversity of combinatorial libraries: a prerequisite for broad activity. J Chem Inf Comput Sci. 2003;43:987–1003. [PubMed]
17. Cristau P, Vors JP, Zhu J. Solid-phase synthesis of natural product-like macrocycles by a sequence of Ugi-4CR and SNAr-based cycloetherification. Tetrahedron Lett. 2003;44:5575–5578.
18. Temal-Lab T, Chastanet J, Zhu J. A convergent approach to cyclopeptide alkaloids: total synthesis of sanjoinine G1. J Am Chem Soc. 2002;124:583–590. [PubMed]
19. Swamy KCK, Kumar NNB, Balaraman E, Kumar KVPP. Mitsunobu and related reactions: advances and applications. Chem Rev. 2009;109:2551–2651. [PubMed]
21. Jensen KJ, Alsina J, Songster MF, Vágner J, Albericio F, Barany G. Backbone amide linker (BAL) strategy for solid-phase Synthesis of C-terminal-modified and cyclic peptides. J Am Chem Soc. 1998;120:5441–5452.
22. Boas U, Brask J, Jensen K. Backbone amide linker in solid-phase synthesis. J Chem Rev. 2009;109:2092–2118. [PubMed]
23. Higher loading levels were obtained using Lanterns functionalized with the monomethoxy BAL as compared to the traditional (dimethoxy) BAL.
24. Akella LB, Marcaurelle LA. Application of a sparse matrix design strategy to the synthesis of DOS libraries. ACS Comb Sci. 2011;13:365–374. [PMC free article] [PubMed]
25. The master list of reagents used for library enumeration is provided in reference 24. Some building blocks were removed due to synthetic feasibility. Sulfonyl chlorides 2, 3 and 11 were also added.
26. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26. [PubMed]
27. While the use of aldehydes for reductive alkylation was investigated, cleavage yields for the resulting products were generally low.
28. Please see Supporting Information for solid-phase experimental procedures and reaction conditions for N-capping.
29. The theoretical loading level for the L-series BAL functionalized Lanterns is 15 μmol/Lantern however the highest loading levels that could routinely be obtained for the HtoT scaffolds was ~10 μmol even with an excess of scaffold.